Design, synthesis, and antiproliferative activity of new indole/1,2,4‐triazole/chalcone hybrids as EGFR and/or c‐MET inhibitors
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202300562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Esraa Mahmoud und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, Minia, Egypt. Hauptthemen laut MEDLINE: ErbB Receptors, Proto-Oncogene Proteins c-met, Antineoplastic Agents, Cell Proliferation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.
Abstract (Originalsprache)
A novel group of indolyl‐1,2,4‐triazole‐chalcone hybrids was designed, synthesized, and assessed for their anticancer activity. The synthesized compounds exhibited significant antiproliferative activity. Compounds 9a and 9e exhibited significant cancer inhibition with GI 50 ranging from 3.69 to 20.40 µM and from 0.29 to >100 µM, respectively. Both compounds displayed a broad spectrum of anticancer activity with selectivity ratios ranging between 0.50–2.78 and 0.25–2.81 at the GI 50 level, respectively. The synthesized compounds were also screened for their cytotoxicity by 3‐(4,5‐dimethylthiazole‐2‐yl)‐2,5‐diphenyltetrazol (MTT) assay and for inhibition of epidermal growth factor receptor (EGFR) and c‐MET (mesenchymal‐epithelial transition factor). Some of the tested compounds exhibited significant inhibition against EGFR and/or c‐MET. Compound 9b showed the highest c‐MET inhibition (IC 50 = 4.70 nM) compared to foretinib (IC 50 = 2.5 nM). Compound 9d showed equipotent activity compared with erlotinib against EGFR (IC 50 = 0.052 µM) and displayed significant c‐MET inhibition with an IC 50 value of 4.90 nM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, Minia, Egypt.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.
- Raabe College of Pharmacy, Ohio Northern University, Ohio, USA.
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
- Pharmacology Department, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sphinx University, New-Assiut, Egypt.
ORCID-Profile: Dalia Abdelhamid
Förderung
- None
Zitieren
APA
Mahmoud, E., Abdelhamid, D., Youssif, B. G. M., Gomaa, H. A. M., Hayallah, A. M., & Abdel-Aziz, M. (2024). Design, synthesis, and antiproliferative activity of new indole/1,2,4‐triazole/chalcone hybrids as EGFR and/or c‐MET inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300562
Vancouver
Mahmoud E, Abdelhamid D, Youssif BGM, Gomaa HAM, Hayallah AM, Abdel-Aziz M. Design, synthesis, and antiproliferative activity of new indole/1,2,4‐triazole/chalcone hybrids as EGFR and/or c‐MET inhibitors. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300562
BibTeX
@article{Mahmoud2024,
author = {Mahmoud, Esraa and Abdelhamid, Dalia and Youssif, Bahaa G M and Gomaa, Hesham A M and Hayallah, Alaa M and Abdel-Aziz, Mohamad},
title = {Design, synthesis, and antiproliferative activity of new indole/1,2,4‐triazole/chalcone hybrids as EGFR and/or c‐MET inhibitors},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202300562}
}
EUVIMED